EMTREE drug terms: cyclophosphamide; doxorubicin; paclitaxel; technetium 99m; trastuzumab; troponin I EMTREE medical terms: add on therapy; cancer combination chemotherapy; cardiac risk score; cell labeling; clinical trial (topic); electrocardiogram; erythrocyte; follow up; heart function; heart injury; heart left ventricle ejection fraction; heart ventricle enddiastolic pressure; human; letter; named inventories, questionnaires and rating scales; priority journal; protein blood level; validity MeSH: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Heart Failure; Humans; Receptor, Epidermal Growth Factor Medline is the source for the MeSH terms of this document.
Questionable Validity of Cardiac Risk Score on the Basis of the NSABP B-31 Model
PITINI, Vincenzo;MONDELLO, PATRIZIA;ALTAVILLA, Giuseppe
2013-01-01
Abstract
EMTREE drug terms: cyclophosphamide; doxorubicin; paclitaxel; technetium 99m; trastuzumab; troponin I EMTREE medical terms: add on therapy; cancer combination chemotherapy; cardiac risk score; cell labeling; clinical trial (topic); electrocardiogram; erythrocyte; follow up; heart function; heart injury; heart left ventricle ejection fraction; heart ventricle enddiastolic pressure; human; letter; named inventories, questionnaires and rating scales; priority journal; protein blood level; validity MeSH: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Heart Failure; Humans; Receptor, Epidermal Growth Factor Medline is the source for the MeSH terms of this document.Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
